Howe & Rusling’s CareDx CDNA Stock Holding History

Howe & Rusling’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-100	Closed	-$4K	–	834
2019 Q2	$4K	Hold	100	–	–	﹤0.01%	556
2019 Q1	$3K	Hold	100	–	–	﹤0.01%	600
2018 Q4	$3K	Hold	100	–	–	﹤0.01%	604
2018 Q3	$3K	Hold	100	–	–	﹤0.01%	663
2018 Q2	$1K	Buy	+100	New	+$1.15K	﹤0.01%	727

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Howe & Rusling's CDNA Position: Q3 2019 in Review

Howe & Rusling sold out of CareDx (CDNA) in Q3 2019, closing a stake of 100 shares — an estimated $4K sold.

Howe & Rusling first reported a position in CDNA in Q2 2018 and held it in 5 quarters. The position peaked at $4K in Q2 2019. 174 funds tracked by Wall St. Rank hold CDNA as of Q3 2019.

Howe & Rusling reported no remaining CareDx position as of Q3 2019 after selling out during the quarter.
Howe & Rusling sold 100 CareDx shares in Q3 2019, an estimated $4K.
Howe & Rusling first reported a position in CareDx in Q2 2018 and held it in 5 quarters.
Howe & Rusling's CareDx position peaked at $4K in Q2 2019.
174 funds tracked by Wall St. Rank held CareDx as of Q3 2019.

Based on Howe & Rusling's 13F filing for Q3 2019, filed 31 Oct 2019.